QuatRx Pharmaceuticals' Series C Round

QuatRx Pharmaceuticals raised a round of funding on June 12, 2003.

QuatRx Pharmaceuticals Company is focused on discovering, licensing, developing and commercializing compounds in the endocrine, metabolic and cardiovascular therapeutic areas. In addition to QRX-431, …

Articles about QuatRx Pharmaceuticals' Series C Round: